来源:猎云精选,文/韩文静山东跑出一个血液透析龙头。2月26日,山东威高血液净化制品股份有限公司(以下简称“威高血净”)沪市主板IPO在上交所上市委审议通过。威高血净成立于2004年,围绕血液透析和腹膜透析两大战略方向,完成了包含透析器、透析机、血液管路、腹膜透析液在内的血液净化全产业链布局。如此一幕,背后最大赢家浮现——威高集团。目前,威高集团拥有威高股份、威高骨科、华东数控三个上市主体,总市值...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.